Chronic hepatitis C virus (HCV) infection is a common cause of serious liver diseases, including cirrhosis and hepatocellular carcinoma. Approximately 2% of the world's population is infected with this virus, rendering it a major health threat. In the U.S., treatment with a combination of interferon-alpha and ribavirin, the only currently licensed therapies for this disease, eliminates the virus from less than 50% of those infected with the most prevalent HCV genotype, genotype 1. HCV NS3 encodes several important enzyme activities required for RNA replication, including protease, helicase and NTPase. NS3 as the protease is essential for viral replication as it proteolytically processes viral polyprotein, which is required for viral replicase complex assembly, and thus an important target in antiviral drug development efforts against HCV infection. The goal of this project is to understand the molecular mechanism of action of NS3 protein in HCV RNA replication in cultured Huh7 cells, by examining HCV replicon mutants, which have shown significant differences in transient replication levels, with a few amino acid changes within the protease domain of the NS3.
The aims of this project are:
Specific aim1 : To determine if replication-enhancing mutations in NS3 alter HCV nonstructural protein processing and to determine whether altered nonstructural protein processing results in differential RNA replication;
Specific aim 2 : To determine if NS3 modulates RNA replication through interaction with NS5A. The outcome of this application will enhance basic molecular biological knowledge concerning viral RNA replication, improve the currently available system to study HCV, and help future drug development efforts leading to enhanced therapy against this dangerous pathogen.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21AI063451-01A1
Application #
6967102
Study Section
Special Emphasis Panel (ZRG1-IDM-G (90))
Program Officer
Koshy, Rajen
Project Start
2005-06-15
Project End
2007-05-31
Budget Start
2005-06-15
Budget End
2006-05-31
Support Year
1
Fiscal Year
2005
Total Cost
$188,750
Indirect Cost
Name
University of Texas Medical Br Galveston
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
800771149
City
Galveston
State
TX
Country
United States
Zip Code
77555
Yi, Minkyung; Lemon, Stanley M (2009) Genotype 1a HCV (H77S) infection system. Methods Mol Biol 510:337-46
Ma, Yinghong; Yates, Jeremy; Liang, Yuqiong et al. (2008) NS3 helicase domains involved in infectious intracellular hepatitis C virus particle assembly. J Virol 82:7624-39
Yi, MinKyung; Ma, Yinghong; Yates, Jeremy et al. (2007) Compensatory mutations in E1, p7, NS2, and NS3 enhance yields of cell culture-infectious intergenotypic chimeric hepatitis C virus. J Virol 81:629-38
Ishida, Hisashi; Li, Kui; Yi, Minkyung et al. (2007) p21-activated kinase 1 is activated through the mammalian target of rapamycin/p70 S6 kinase pathway and regulates the replication of hepatitis C virus in human hepatoma cells. J Biol Chem 282:11836-48
Yang, Yan; Liang, Yuqiong; Qu, Lin et al. (2007) Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor. Proc Natl Acad Sci U S A 104:7253-8
Yi, MinKyung; Villanueva, Rodrigo A; Thomas, David L et al. (2006) Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells. Proc Natl Acad Sci U S A 103:2310-5
Yi, MinKyung; Tong, Xiao; Skelton, Angela et al. (2006) Mutations conferring resistance to SCH6, a novel hepatitis C virus NS3/4A protease inhibitor. Reduced RNA replication fitness and partial rescue by second-site mutations. J Biol Chem 281:8205-15
Jopling, Catherine L; Yi, Minkyung; Lancaster, Alissa M et al. (2005) Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 309:1577-81
Cai, Zhaohui; Yi, MinKyung; Zhang, Chen et al. (2005) Mutagenesis analysis of the rGTP-specific binding site of hepatitis C virus RNA-dependent RNA polymerase. J Virol 79:11607-17